RxDoctor Payments Data

Brittany Cox, PA

Surgical · Fresno, CANPI 1992027965

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $4,154 of the $5,010 with a category attached, or 82.9%. It is spread thinly across 34 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $2,734 and has fallen 53.4% since, to $1,275 in 2025. Among surgical clinicians in CA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,010in general payments, 2019–2025

Across 96 payments — averaging $52.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$1K
  • AbbVie$561
  • Neurocrine Biosciences, Inc.$393
  • Acadia Pharmaceuticals Inc$302
  • Abiomed$257
  • Novo Nordisk$250
  • plus $2K from 28 others

What the payments were for

  • Travel & lodging$85617%
  • Food & beverage$4,15483%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,010 in reported general payments places this provider in the 90th percentile of 729 surgical providers in California.

See all surgical providers in California

Medicare billing

Part B allowed, 2024
$22,727
Medicare patients
149
Services billed
186

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban17$8,260
ClopidogrelClopidogrel Bisulfate17$233
Gabapentin16$210
Atorvastatin Calcium13$64

Paid to pharmacies, not to this prescriber.

Other surgical in Fresno

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →